Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody–Drug Conjugate Therapy
Ravi K Goyal,1 Jingchuan Zhang,2 Keith L Davis,1 Martina Sluga-O’Callaghan,1 Peter A Kaufman3 1Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA; 2Eisai Inc., Nutley, NJ, USA; 3Larner College of Medicine, Division of Hematology/Oncology, University of Vermont Cancer Center, Bur...
Main Authors: | Goyal RK, Zhang J, Davis KL, Sluga-O'Callaghan M, Kaufman PA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-11-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/early-real-world-treatment-patterns-and-clinical-outcomes-in-patients--peer-reviewed-fulltext-article-BCTT |
Similar Items
-
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia
by: L V Bolotina, et al.
Published: (2016-09-01) -
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
by: Renaud Sabatier, et al.
Published: (2021-03-01) -
Efficacy of Eribulin in Soft Tissue Sarcomas
by: Edward Phillips, et al.
Published: (2022-03-01) -
Effectiveness, safety, and impact on quality of life of eribulin‐based therapy in heavily pretreated patients with metastatic breast cancer: A real‐world analysis
by: Xinyu Gui, et al.
Published: (2023-08-01) -
Eribulin alongwith capecitabine in relapsed carcinoma breast- a retrospective single-Institutional study.
by: Soumita Poddar, et al.
Published: (2023-08-01)